SEARCH

SEARCH BY CITATION

References

  • 1
    Collen, D. & Lijnen, H. R. (1991) Basic and clinical aspects of fibrinolysis and thrombolysis, Blood 78, 31143124.
  • 2
    Bachmann, F. (1993) in Hemostasis and thrombosis: basic principles and clinical practice (Colman, R. W., Hirsch, J., Marder, V. J. & Salzman, E. W., eds) 3rd edn, pp. 15921622. J. B. Lippincott, Philadelphia .
  • 3
    Vassalli, J. D., Sappino, A. P. & Belin, D. (1991) The plasminogen activator/plasmin system, J. Clin. Invest. 88, 10671072.
  • 4
    Blasi, F. (1993) Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness, BioEssays 15, 105111.
  • 5
    Erickson, L. A., Fici, G. J., Lund, J. E., Boyle, T. P., Polites, H. G. & Marotti, K. R. (1990) Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene, Nature 346, 7476.
  • 6
    Heckel, J. L., Sandgren, E. P., Degen, J. L., Palmiter, R. D. & Brinster, R. L. (1990) Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator, Cell 62, 447456.
  • 7
    Carmeliet, P., Kieckens, L., Schoonjans, L., Ream, B., Van Nuffelen, A., Prendergast, G., Cole, M., Bronson, R., Collen, D. & Mulligan, R. C. (1993) Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization, J. Clin. Invest. 92, 27462755.
  • 8
    Carmeliet, P., Stassen, J. M., Schoonjans, L., Ream, B., van den Oord, J. J., De Mol, M., Mulligan, R. C. & Collen, D. (1993) Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis and thrombolysis, J. Clin. Invest. 92, 27562760.
  • 9
    Carmeliet, P., Schoonjans, L., Kieckens, L., Ream, B., Degen, J., Bronson, R., De Vos, R., van den Oord, J. J., Collen, D. & Mulligan, R. C. (1994) Physiological consequences of loss of plasminogen activator gene function in mice, Nature 368, 419424.
  • 10
    Summaria, L., Arzadon, L., Bernabe, P. & Robbins, K. C. (1974) The interaction of streptokinase with human, cat, dog, and rabbit plasminogens. The fragmentation of streptokinase in the equimolar plasminogen-streptokinase complexes, J. Biol. Chem. 249, 47604769.
  • 11
    Wohl, R. C., Sinio, L., Summaria, L. & Robbins, K. C. (1993) Comparative activation kinetics of mammalian plasminogen, Biochim. Biophys. Acta 745, 2031.
  • 12
    Irfan, M. (1968) Fribrinolytic activity in animals of different species, J. Exp. Physiol. 53, 374380.
  • 13
    Korninger, C. & Collen, D. (1981) Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro, Thromb. Haemostas. 46, 561565.
  • 14
    Lijnen, H. R., De Wreede, K., Demarsin, E. & Collen, D. (1984) Biological and thrombolytic properties of proenzyme and active forms of human urokinase. IV. Variability in fibrinolytic response of plasma of several mammalian species, Thromb. Haemostas. 52, 3133.
  • 15
    Lijnen, H. R., Marafino, B. J. Jr & Collen, D. (1984) In vitro fibrinolytic activity of recombinant tissue-type plasminogen activator in plasma of various primate species, Thromb. Haemostas. 52, 308310.
  • 16
    Lijnen, H. R., De Cock, F., Matsuo, O. & Collen, D. (1992) Comparative fibrinolytic and fibrinogenolytic properties of staphylokinase and streptokinase in plasma of different species in vitro, Fibrinolysis 6, 3337.
  • 17
    Collen, D., Van Hoef, B., Schlott, B., Hartmann, M., Gührs, C.-H. & Lijnen, H. R. (1993) Mechanisms of activation of mammalian plasma fibrinolytic systems with streptokinase and with recombinant staphylokinase, Eur J. Biochem. 216, 307314.
  • 18
    Lijnen, H. R., Van Hoef, B., De Cock, F. & Collen, D. (1990) Effect of fibrin-like stimulators on the activation of plasminogen by tissue-type plasminogen activator (t-PA), Studies with active site mutagenized plasminogen and plasmin resistant t-PA, Thromb. Haemostas. 64, 6168.
  • 19
    Alessi, M. C., Declerck, P. J., De Mol, M., Nelles, L. & Collen, D. (1988) Purification and characterization of natural and recombinant human plasminogen activator inhibitor-1 (PAI-1), Eur J. Biochem. 175, 531540.
  • 20
    Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72, 248254.
  • 21
    Teger-Nilsson, A. C., Friberger, P. & Gyzander, E. (1977) Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate, Scand. J. Clin. Lab. Invest. 37, 403409.
  • 22
    Holvoet, P., Cleemput, H. & Collen, D. (1985) Assay of human tissue-type plasminogen activator (t-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies to t-PA, Thromb. Haemostas. 54, 684687.
  • 23
    Wiman, B. (1980) Affinity-chromatographic purification of human α2-antiplasmin, Biochem. J. 191, 229232.
  • 24
    Kluft, C. & Los, N. (1981) Demonstration of two forms of α2-antiplasmin in plasma by modified crossed immunoelectrophoresis, Thromb. Res. 21, 6571.
  • 25
    Lijnen, H. R., Van Hoef, B., De Cock, F., Okada, K., Ueshima, S., Matsuo, O. & Collen, D. (1991) On the mechanism of fibrin-specific plasminogen activation by staphylokinase, J. Biol. Chem. 266, 1182611832.
  • 26
    Li, X.-K., Lijnen, H. R., Nelles, L., Van Hoef, B., Stassen, J. M. & Collen, D. (1992) Biochemical and biologic properties of rt-PA del (K296-G302), a recombinant human tissue-type plasminogen activator deletion mutant resistant to plasminogen activator inhibitor-I, Blood 79, 417429.
  • 27
    Verheijen, J. H., Mullaert, E., Chang, G. T. G., Kluft, C. & Wijngaards, G. (1982) A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurement in plasma, Thromb. Haemostas. 48, 266269.
  • 28
    Lijnen, H. R., Van Hoef, B., De Cock, R. & Collen, D. (1989) The mechanism of plasminogen activation and fibrin dissolution by single-chain urokinase-type plasminogen activator in a plasma milieu in vitro, Blood 73, 18641872.
  • 29
    Degen, S. J. F., Bell, S. M., Schaefer, M. A. & Elliott, R. W. (1990) Characterization of the cDNA coding for mouse plasminogen and localization of the gene to mouse chromosome 17, Genomics 8, 4961.
  • 30
    Rickles, R. J., Darrow, A. L. & Strickland, S. (1988) Molecular cloning of complementary DNA to mouse tissue plasminogen activator mRNA and its expression during F9 teratocarcinoma cell differentiation, J. Biol. Chem. 263, 15631569.
  • 31
    Prendergast, G. C., Diamond, L. E., Dahl, D. & Cole, M. D. (1990) The c-myc-regulated gene mr1 encodes plasminogen activator inhibitor 1, Mol. Cell. Biol. 10, 12651269.
  • 32
    Lijnen, H. R., Maes, M., Castel, M., Samama, M. & Collen, D. (1982) Kinetics of the inhibition of plasmin in acidified human plasma, Thromb. Haemostas. 48, 257259.
  • 33
    van Giezen, J. J. J., Minkema, J., Bouma, B. N. & Jansen, J. W. C. M. (1994) Crosslinking of α2-antiplasmin to fibrin is a key factor in regulating blood clot lysis: species differences, Blood Coag. Fibrinol. 4, 869875.
  • 34
    van Giezen, J. J. J., Bouma, B. N. & Jansen, J. W. C. M. (1994) Mice release less tissue-type plasminogen activator (t-PA) and have more active clot stabilization by FXIII compared to rats which might explain their low rate of blood clot lysis, Fibrinolysis 8, 18.